In a significant move toward enhancing its corporate governance and market presence, Earth Science Tech, Inc. (OTC: ETST) announced that shareholders have approved a series of strategic measures during the company's first Annual Meeting of Stockholders, held virtually on August 31, 2026. The approved proposals include a reverse stock split, the retirement of Series B Preferred Stock, and the adoption of a cash-only executive compensation structure, among others.
The reverse stock split authorization, valid for 12 months, will be utilized only if the board of directors deems it necessary to satisfy the minimum bid-price requirements for an uplisting to a national securities exchange. This move is part of the company's broader strategy to potentially qualify for listing on a major exchange, which could increase liquidity and broaden its investor base.
Shareholders also authorized the board's independent Special Committee to negotiate the retirement of the Series B Preferred Stock. This action is intended to eliminate the dual-class, super-voting control structure, thereby simplifying the company's equity structure and aligning with best practices in corporate governance. The retirement of the preferred stock could enhance the voting power of common shareholders and make the company more attractive to institutional investors.
Additionally, shareholders approved a cash-only “Say-on-Pay” executive compensation structure, with a three-year review cycle, and re-elected all seven director nominees. The ratification of Semple, Marchal & Cooper, LLP as the independent registered public accounting firm was also approved. According to the company, an audio replay of the meeting will be available, providing management guidance and additional details on the approved proposals, as well as a shareholder question-and-answer session.
Earth Science Tech operates as a diversified holding company focused on the health and wellness sector. Its principal operating strategy is to build a vertically integrated healthcare platform that combines compounding pharmacy operations, telemedicine platforms, clinical support, and direct-to-patient fulfillment. The company's healthcare operations are supported by investments in real estate and asset management activities and a consumer products business. The core of its value proposition is the seamless integration of patient care, from consultation to fulfillment, achieved through the synergy of specialized subsidiaries.
The shareholder approvals mark a pivotal step for Earth Science Tech as it seeks to strengthen its position in the market. The potential uplisting to a national exchange could provide the company with greater visibility and access to capital, while the retirement of the Series B Preferred Stock could streamline its capital structure and potentially improve investor sentiment.
For more information on the company's latest news and updates, visit its newsroom at https://ibn.fm/ETST.
This development is part of a broader trend among small-cap companies to pursue governance improvements and exchange uplisting to attract institutional investment and enhance shareholder value. As Earth Science Tech moves forward with these measures, industry observers will be watching to see how these changes impact its operational performance and market standing.
